- Home
- BSBK vs FATE Comparison
BSBK vs FATE Comparison
Compare BSBK & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSBK | FATE |
|---|---|---|
| Founded | 1893 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.0M | 125.6M |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BSBK | FATE |
|---|---|---|
| Price | $9.06 | $2.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.10 |
| AVG Volume (30 Days) | 8.8K | ★ 4.5M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 200.00 | 29.88 |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | ★ $6,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $151.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.90 | $0.91 |
| 52 Week High | $9.49 | $3.21 |
Technical Indicators
Market Signals| Indicator | BSBK | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 67.37 |
| Support Level | $8.83 | $1.01 |
| Resistance Level | $9.29 | N/A |
| Average True Range (ATR) | 0.12 | 0.28 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 62.50 | 79.34 |
Price Performance
Historical ComparisonAbout BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey. The Company operates one reportable segment of business, retail banking. Through its community banking segment, the Company provides a broad range of retail and commercial banking services.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.